Reagent Kit for Determining HDL Cholesterol Concentration by Direct Immunoinhibition Method in Serum and Plasma (HDL CHOLESTEROL (Direct Immuno) DiaS) according to TU 21.20.23.110-077-48813770-2013

The reagent kit for determining the concentration of high-density lipoprotein cholesterol (HDL-C) by direct immunoinhibition method consists of the following:

Components:

Reagent 1: Buffer-enzyme solution (pH 7.0), containing:
- Good's Buffer, 25 mmol/L
- 4-Aminoantipyrine, 0.75 mmol/L
- Peroxidase (POD), 2.0 kE/L
- Ascorbate oxidase, 2.25 kE/L
- Antibodies to human lipoproteins
- Sodium azide, 0.95 g/L
Reagent 2: Buffer-enzyme solution (pH 7.0), containing:
- Good's Buffer, 30 mmol/L
- Cholesterol esterase (CE), 4.0 kE/L
- Cholesterol oxidase (CO), 20 kE/L
- F-DAOS [N-ethyl-N-(2-hydroxy-3-sulphopropyl)-3,5-dimethoxy-4-fluoroaniline sodium salt], 0.8 mmol/L
- Sodium azide, 0.95 g/L

Variants of Execution:

Variant 1:
- Reagent 1: 5 bottles of 20 ml each
- Reagent 2: 1 bottle of 25 ml
Variant 2:
- Reagent 1: 2 bottles of 68 ml each
- Reagent 2: 2 bottles of 17 ml each
Variant 3:
- Reagent 1: 6 bottles of 68 ml each
- Reagent 2: 6 bottles of 17 ml each

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Reagent Kit for Determining HDL Cholesterol Concentration by Direct Immunoinhibition Method in Serum and Plasma (HDL CHOLESTEROL (Direct Immuno) DiaS) according to TU 21.20.23.110-077-48813770-2013, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.

Back